Our mission is to transform the rapidly evolving field of in vitro experimental models of disease and ADME/Tox ranging from traditional cell based assays to organoids and structured microphysiology systems through a comprehensive computational and systems biology analytics platform. The BioSystics platform accesses, manages, analyzes, shares and computationally models complex data sets from in vitro experimental models, animal models and human clinical data creating actionable knowledge and predicting biological outcomes that will accelerate and optimize drug discovery/development, as well as cosmetic, industrial and environmental chemical testing.
Company Details
- Founded
- -
- Address
- Pittsburgh, Pa 15215, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.numabio.com/
- Keywords
- Streamlined workflow across study lifecycle, Assessment of study reproducibility through statistical tools, Algorithm powered data comparison within and across studies and models, Power analysis to optimize study design, Integration with clinical and compound information, Complex Omics datasets analysis, Computational Modeling, PBPK analysis.
- HQ
- Pittsburgh, PA
Biosystics, Inc. Questions
Biosystics, Inc.'s website is https://www.numabio.com/
Biosystics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/biosystics
Biosystics, Inc.'s industry is
Biotechnology Research
Biosystics, Inc.'s top competitors are
Bullseye Biotechnologies, Inc,
Iprocess Global Research Inc,
Brainstorm Therapeutics, Inc.,
Nextvivo,
Otobiology Leiden,
Zeneuroid,
Hopstem Biotechnology Co., Ltd.,
3d-Hub-O,
Oddity Labs.
Biosystics, Inc.'s categories are Biotechnology Research
Biosystics, Inc.'s founding year is 2021
